{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:04:24Z","timestamp":1761156264100},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T00:00:00Z","timestamp":1488153600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s40618-017-0634-x","type":"journal-article","created":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T05:58:52Z","timestamp":1488175132000},"page":"745-752","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Effect of metformin and oral contraceptives on polycystic ovary syndrome and IVF cycles"],"prefix":"10.1007","volume":"40","author":[{"given":"M. N.","family":"Kalem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Kalem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Gurgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,27]]},"reference":[{"issue":"1","key":"634_CR1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/humrep\/der396","volume":"27","author":"BCJM Fauser","year":"2012","unstructured":"Fauser, BCJM, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, Barnhart K (2012) Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS). Hum Reprod 27(1):14\u201324","journal-title":"Hum Reprod"},{"issue":"3","key":"634_CR2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.fertnstert.2007.09.041","volume":"89","author":"TT ESHRE","year":"2008","unstructured":"ESHRE TT, Group ASPCW (2008) Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 89(3):505\u2013522","journal-title":"Fertil Steril"},{"issue":"2","key":"634_CR3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.21613\/GORM.2016.54","volume":"22","author":"MN Kalem","year":"2016","unstructured":"Kalem MN, Kalem Z, G\u00fcrgan T (2016) Problems and complications during the treatment of infertility in women with polycystic ovary syndrome. Gynecol Obstet Reprod Med 22(2):113\u2013124","journal-title":"Gynecol Obstet Reprod Med"},{"key":"634_CR4","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s40618-015-0372-x","volume":"38","author":"MC Amato","year":"2015","unstructured":"Amato MC et al (2015) Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance. J Endocrinol Invest 38:1319\u20131326","journal-title":"J Endocrinol Invest"},{"key":"634_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40618-016-0523-8","volume":"40","author":"K Polak","year":"2017","unstructured":"Polak K et al (2017) New markers of insulin resistance in polycystic ovary syndrome. J Endocrinol Invest 40:1\u20138","journal-title":"J Endocrinol Invest"},{"key":"634_CR6","first-page":"CD003053","volume":"16","author":"T Tang","year":"2012","unstructured":"Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH (2012) Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 16:CD003053","journal-title":"Cochrane Database Syst Rev"},{"key":"634_CR7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/GCO.0b013e328332d188","volume":"21","author":"S Palomba","year":"2009","unstructured":"Palomba S, Falbo A, Zullo F (2009) Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance. Curr Opin Obstet Gynecol 21:465\u2013473","journal-title":"Curr Opin Obstet Gynecol"},{"key":"634_CR8","first-page":"CD006105","volume":"2","author":"LO Tso","year":"2009","unstructured":"Tso LO, Costello MF, Albuquerque LE, Andriolo RB, Freitas V (2009) Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2:CD006105","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"634_CR9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4103\/2348-2907.127082","volume":"1","author":"VC Karande","year":"2014","unstructured":"Karande VC (2014) Use of oral contraceptives in assisted reproductive cycles. IVF Lite 1(1), 6.","journal-title":"IVF Lite"},{"key":"634_CR10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1472-6483(10)60621-9","volume":"13","author":"JA Huirne","year":"2006","unstructured":"Huirne JA, van Loenen AC, Donnez J, Pirard C, Homburg R, Schats R et al (2006) Effect of an oral contraceptive pill on follicular development in IVF\/ICSI patients receiving a GnRH antagonist: a randomized study. Reprod Biomed Online 13:235\u2013245","journal-title":"Reprod Biomed Online"},{"key":"634_CR11","first-page":"874-85","volume":"17","author":"H Al-Inany","year":"2002","unstructured":"Al-Inany H, Aboulghar M (2002) GnRH antagonist in assisted reproduction: a cochrane review. Hum Reprod 17:874-85","journal-title":"Hum Reprod"},{"issue":"1","key":"634_CR12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"TR ESHRE","year":"2004","unstructured":"ESHRE TR, Group ASPCW (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81(1):19\u201325","journal-title":"Fertil Steril"},{"issue":"6","key":"634_CR13","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/humrep\/deh248","volume":"19","author":"SB Kj\u00f8tr\u00f8d","year":"2004","unstructured":"Kj\u00f8tr\u00f8d SB, von D\u00fcring V, Carlsen SM (2004) Metformin treatment before IVF\/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study. Hum Reprod 19(6):1315\u20131322","journal-title":"Hum Reprod"},{"issue":"6","key":"634_CR14","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/humrep\/dei501","volume":"21","author":"MF Costello","year":"2006","unstructured":"Costello MF, Chapman M, Conway U (2006) A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome. Hum Reprod 21(6):1387\u20131399","journal-title":"Hum Reprod"},{"issue":"6","key":"634_CR15","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/humrep\/del025","volume":"21","author":"T Tang","year":"2006","unstructured":"Tang T, Glanville J, Orsi N, Barth JH, Balen AH (2006) The use of metformin for women with PCOS undergoing IVF treatment. Hum Reprod 21(6):1416\u20131425","journal-title":"Hum Reprod"},{"issue":"2","key":"634_CR16","first-page":"2711","volume":"8","author":"L Wang","year":"2015","unstructured":"Wang L, Zhao Y, Dong X, Huang K, Wang R, Ji L, Zhang H (2015) Could pretreatment with oral contraceptives before pituitary down regulation reduce the incidence of ovarian hyperstimulation syndrome in the IVF\/ICSI procedure? Int J Clin Exper Med 8(2):2711","journal-title":"Int J Clin Exper Med"},{"key":"634_CR17","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1093\/humrep\/der318","volume":"26","author":"AN Andersen","year":"2011","unstructured":"Andersen AN, Witjes H, Gordon K, Mannaerts B (2011) Xpect investigators. Predictive factors of ovarian response and clinical outcome after IVF\/ICSI following a rFSH\/GnRH antagonist protocol with or without oral contraceptive pre-treatment. Hum Reprod 26:3413\u20133423","journal-title":"Hum Reprod"},{"key":"634_CR18","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.fertnstert.2007.07.1354","volume":"90","author":"G Griesinger","year":"2008","unstructured":"Griesinger G, Venetis CA, Marx T, Diedrich K, Tarlatzis BC, Kolibianakis EM (2008) Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis. Fertil Steril 90:1055\u20131063","journal-title":"Fertil Steril"},{"key":"634_CR19","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/humrep\/dei348","volume":"21","author":"EM Kolibianakis","year":"2006","unstructured":"Kolibianakis EM, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem AC, Devroey P (2006) Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum Reprod 21:352\u2013357","journal-title":"Hum Reprod"},{"issue":"3","key":"634_CR20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(00)01766-0","volume":"75","author":"LA Stadtmauer","year":"2001","unstructured":"Stadtmauer LA, Toma SK, Riehl RM, Talbert LM (2001) Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors. Fertil Steril 75(3):505\u2013509","journal-title":"Fertil Steril"},{"issue":"1","key":"634_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7827-11-54","volume":"11","author":"C Decanter","year":"2013","unstructured":"Decanter C, Robin G, Thomas P, Leroy M, Lefebvre C, Soudan B, Dewailly D (2013) First intention IVF protocol for polycystic ovaries: does oral contraceptive pill pretreatment influence COH outcome? Reprod Biol Endocrinol 11(1):1","journal-title":"Reprod Biol Endocrinol"},{"issue":"7","key":"634_CR22","first-page":"623","volume":"18","author":"CC Wu","year":"2012","unstructured":"Wu CC, Lei P, Ruan YM, Lin XM, Xiong YL, Yang GY (2012) Effects of oral contraceptive pretreatment on controlled ovarian hyperstimulation and outcomes of IVF-ET. Zhonghua Nan Ke Xue 18(7):623\u2013626 (Chinese)","journal-title":"Zhonghua Nan Ke Xue"},{"issue":"11","key":"634_CR23","doi-asserted-by":"publisher","first-page":"23592365","DOI":"10.1093\/humrep\/12.11.2359","volume":"12","author":"MA Damario","year":"1997","unstructured":"Damario MA, Barmat L, Liu HC, Davis OK, Rosenwaks Z (1997) Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients. Hum Reprod 12 (11): 2359\u20132365. doi:\n10.1093\/humrep\/12.11.2359","journal-title":"Hum Reprod"},{"issue":"1","key":"634_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humupd\/dms040","volume":"19","author":"T Tang","year":"2013","unstructured":"Tang T, Balen AH (2013) Use of metformin for women with polycystic ovary syndrome. Hum Reprod Update 19(1):1\u20131","journal-title":"Hum Reprod Update"},{"issue":"6","key":"634_CR25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/humupd\/dmm026","volume":"13","author":"E Moll","year":"2007","unstructured":"Moll E, van der Veen F, van Wely M (2007) The role of metformin in polycystic ovary syndrome: a systematic review. Hum Reprod Update 13(6):527\u2013537","journal-title":"Hum Reprod Update"},{"issue":"5","key":"634_CR26","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1210\/jc.2011-3061","volume":"97","author":"L Morin-Papunen","year":"2012","unstructured":"Morin-Papunen L, Rantala AS, Unkila-Kallio L, Tiitinen A, Hippel\u00e4inen M, Perheentupa A, Tapanainen JS (2012) Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial. J Clin Endocrinol Metab 97(5):1492\u20131500","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"634_CR27","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.fertnstert.2015.05.038","volume":"104","author":"LO Tso","year":"2015","unstructured":"Tso LO, Costello MF, Albuquerque LET, Andriolo RB, Marjoribanks J, Macedo CR (2015) Metformin treatment before and during in vitro fertilization or intracytoplasmic sperm injection in women with polycystic ovary syndrome: summary of a Cochrane review. Fertil Steril 104(3):542\u2013544","journal-title":"Fertil Steril"},{"issue":"4","key":"634_CR28","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3109\/09513590.2014.995621","volume":"31","author":"JX Pan","year":"2015","unstructured":"Pan JX, Liu Y, Ke ZH, Zhou CL, Meng Q, Ding GL, Xu GF, Sheng JZ, Huang HF (2015) Successive and cyclic oral contraceptive pill pretreatment improves IVF\/ICSI outcomes of PCOS patients and ameliorates hyperandrogenism and antral follicle excess. Gynecol Endocrinol 31(4):332\u2013336. doi:\n10.3109\/09513590.2014.995621\n\n Epub 2015 Jan 5","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"634_CR29","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1016\/j.fertnstert.2015.07.452","volume":"104","author":"W Wang","year":"2015","unstructured":"Wang W, Tang Y, Liu H (2015) Protective effects of DHEA and metformin on the viability of early embryos under oxidative stress are mediated by sustaining mitochondrial biogenesis. Fertil Steril 104(3):e146\u2013e147","journal-title":"Fertil Steril"},{"issue":"2","key":"634_CR30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijgo.2015.04.046","volume":"131","author":"X Huang","year":"2015","unstructured":"Huang X, Wang P, Tal R, Lv F, Li Y, Zhang X (2015) A systematic review and meta-analysis of metformin among patients with polycystic ovary syndrome undergoing assisted reproductive technology procedures. Int J Gynecol Obstet 131(2):111\u2013116","journal-title":"Int J Gynecol Obstet"},{"issue":"3","key":"634_CR31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/1471-0528.12070","volume":"120","author":"S Palomba","year":"2013","unstructured":"Palomba S, Falbo A, La Sala GB (2013) Effects of metformin in women with polycystic ovary syndrome treated with gonadotrophins for in vitro fertilisation and intracytoplasmic sperm injection cycles: a systematic review and meta-analysis of randomised controlled trials. BJOG 120(3):267\u2013276","journal-title":"BJOG"},{"issue":"6","key":"634_CR32","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.fertnstert.2011.09.020","volume":"96","author":"S Palomba","year":"2011","unstructured":"Palomba S, Falbo A, Carrillo L, Villani MT, Orio F, Russo T, Colao A (2011) Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial. Fertil Steril 96(6):1384\u20131390","journal-title":"Fertil Steril"},{"key":"634_CR33","doi-asserted-by":"crossref","unstructured":"Swanton A, Lighten A, Granne I, McVeigh E, Lavery S, Trew G, Child T (2011) Do women with ovaries of polycystic morphology without any other features of PCOS benefit from short-term metformin co-treatment during IVF? A double-blind, placebo-controlled, randomized trial. Hum Reprod der120","DOI":"10.1093\/humrep\/der120"},{"issue":"10","key":"634_CR34","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/humrep\/dei130","volume":"20","author":"S Palomba","year":"2005","unstructured":"Palomba S, Falbo A, Orio F, Manguso F, Russo T, Tolino A, Zullo F (2005) A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination. Hum Reprod 20(10):2879\u20132886","journal-title":"Hum Reprod"},{"issue":"2","key":"634_CR35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5152\/jtgga.2016.15235","volume":"17","author":"MN Kalem","year":"2016","unstructured":"Kalem MN, Kalem Z, Sar\u0131 T, Ate\u015f C, G\u00fcrgan T (2016) Effect of body mass index and age on in vitro fertilization in polycystic ovary syndrome. J Turkish Ger Gynecol Assoc 17(2):83","journal-title":"J Turkish Ger Gynecol Assoc"},{"issue":"8","key":"634_CR36","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s40618-016-0446-4","volume":"39","author":"Y \u00c7ak\u0131ro\u011flu","year":"2016","unstructured":"\u00c7ak\u0131ro\u011flu Y, Vural F, Vural B (2016) The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes. J Endocrinol Invest 39(8):899\u2013907","journal-title":"J Endocrinol Invest"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-017-0634-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-017-0634-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-017-0634-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T14:47:20Z","timestamp":1497019640000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-017-0634-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,27]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["634"],"URL":"https:\/\/doi.org\/10.1007\/s40618-017-0634-x","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,27]]}}}